Barclays analyst Lauren Lieberman maintains Clorox (NYSE:CLX) with a Underweight and raises the price target from $122 to $130.
Barclays Maintains Underweight on Clorox, Raises Price Target to $130
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.